12 employees
Double Bond Pharmaceutical company which develops and commercialises innovative first-in-class approaches for treatment of cancers.
2014
$82K
from 1 investors over 1 rounds
Double Bond Pharmaceutical International AB raised $82K on January 1, 2019
Investors: Executive Agency for Small and Medium-sized Enterprises (EASME)